Technology Offerings

We propose a fundamentally new, direct solution for real-time monocular SLAM/Odometry (VO). The method runs in real-time on a laptop CPU or modern smart phone. In addition to accurate and robust camera-tracking, it estimates precise, semi-dense depth maps.

The invention describes SiC/Graphene Transistors for Normally-On/Normally-Off Operation and Integrated Circuits (Including Logic). This invention can be used, e.g. to
build a compact constant current source for LED-lightning,
include the control circuits and the LED on the same SiC-subtrate and/or provide control circuits for high power switches.

Transitional cell carcinoma (TCC) of the urinary bladder is the most common genitourinary cancer. Diagnosis of TCC currently relies on cystoscopy and urine cytology. Both examination methods have limitations. The present technology describes a novel urinary marker for the detection of bladder cancer. With a sensitivity of 85 % and a specificity of 86.4 % the potential marker exceeds currently commercially available bladder cancer associated marker proteins.

The field of application is under water welding (e.g. offshore platforms or inland water-ways) using electric arc welding including continuous filler wire supply. In comparison to the state of the art, the new welding system allows a creation of endless an slag-free welding seam in hyper-baric wet areas by the hand of the diver.

To date, the diagnosis of the severe infectious disease leishmaniosis is still highly unreliable in endemic areas of Eastern Africa, since the pathogen occurring in these regions differs from pathogens present in other endemic areas of South Africa and Asia. Moreover, leishmaniasis is also spreading in southern Europe because infected dogs represent a major source of risk for the transmission to humans.

A cost-effective and time-efficient diagnostics was developed which provides a more
reliable diagnosis of leishmaniasis in humans and animals as compared to currently
available diagnostics. This diagnostics is particularly suitable for a use as rapid test,
allowing an uncomplicated application outside of clinics and laboratories and
consequently a more efficient and improved diagnosis of leishmaniasis in hospitals
and in the field.

Several pathological conditions as autoimmune and inflammatory diseases are due to an excessive T cell activity. Treatment modalities are based on the relief from symptoms, whereby immune suppressive biologicals are rapidly expanding, owing to the good efficacy and safety profiles. However, for the regulation of the starting point of the disease-causing processes no agents exist until now. For that we offer a new agent with an exceptional stringent and specific suppression of T cell activation, whereby the inactivation is reversible. With this invention it is not only possible to address T cells in their entirety, but also antigen-specific T cells. Membrane mobility characteristics have not to be considered, because the target is located on the outside of T cells.